James Morgan Harris, PhD, Honored for Contributions to the Pharmaceutical Industry
James Morgan Harris, PhD, handles MSAT Conjugation at Pfizer Inc.
CHAPEL HILL, NC, February 07, 2025 /24-7PressRelease/ — James Morgan Harris, PhD, has been selected for inclusion in Marquis Who’s Who. As in all Marquis Who’s Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.
Dr. Harris, a distinguished professional in the field of chemical and biomolecular engineering, has made significant contributions to the pharmaceutical industry, particularly in the development of the Covid-19 vaccine. Currently overseeing MSAT conjugation at Pfizer Inc., he has been instrumental in developing bioprocesses for manufacturing vaccines for several years. Additionally, his expertise in computational fluid dynamics has been pivotal in optimizing process steps, reducing experimental work and enabling remote support during restricted laboratory access.
In addition to his primary role Dr. Harris also serves as the editor-in-chief of BandCN Journal at Pfizer Inc., a position he has held since 2019. Concurrently, he is also a principal scientist at Pfizer Inc., where he oversees major projects requiring high-level nonlinear solution development using high-performance computing. Prior to these roles, he was a senior scientist in process development at Pfizer Inc. from 2015 to 2019, honing his skills in computational methods and CAD drawings.
Before assuming these positions, Dr. Harris served as a development engineer and as a process analyst at Novartis and as a postdoctoral associate and Hartwell Fellow at Duke University from 2010 to 2013. He additionally held an early career position at Pfizer Inc. as a process engineer and contributed to Resolution Analytics, Inc. as a quality control analyst. His foundational experiences in pharmaceuticals were as a graduate research associate and NIH biotechnology trainee at North Carolina State University from 2003 to 2009 and as a research intern at Becton, Dickinson and Company in 2006.
Dr. Harris’s academic achievements are equally impressive. He earned a post-doctorate degree in biomedical and medical engineering from Duke University in 2013, preceded by a PhD in chemical and biomolecular engineering from North Carolina State University in 2009. He also holds a bachelor’s degree in chemical engineering from North Carolina Agricultural and Technical State University, which he obtained in 2002. Beyond his education, he attributes much of his success to his faith and the unwavering support of his family.
Dr. Harris has also contributed significantly to the industry through his work in professional journals, sharing his knowledge and insights with the broader scientific community. His recent patent on novel methods for linking glycogens also highlights his innovative approach to enhancing the efficacy and reproducibility of conjugation processes.
In addition to his professional accomplishments, Dr. Harris is an active member of several industry-related organizations, including the American Chemical Society and Phi Beta Sigma. He is also committed to civic engagement through his roles as a volunteer tutor for Grade Power Learning, a teacher for the Green Awaking Program with Communities In Schools of North Carolina and as a club pack master for the Boy Scouts.
# # #
